通过下一代测序对新型HLA-DQA1*01:140等位基因的表征
Wenwen Pi1, Chen Chen1, Fang Wang1
1HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.
HLA
|July 24, 2025
概括
人类白细胞抗原 (HLA) -DQA1*01:140等位基因是一种新发现的变异. 这种新的HLA等位基因与已知的等位基因不同,在4号外基因中单个核酸替代.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
- 人类白细胞抗原 (HLA) 系统
背景情况:
- 人类白细胞抗原 (HLA) 系统在免疫反应中起着至关重要的作用.
- HLA基因中的遗传变异,例如HLA-DQA1,有助于免疫多样性.
- 精确的HLA类型定型对于移植和疾病关联研究至关重要.
研究的目的:
- 报告一种新的HLA-DQA1等位基因的识别和特征.
- 描述新等位基因与以前已知的等位基因之间的特定遗传差异.
主要方法:
- 在HLA-DQA1基因的核酸测序.
- 对DNA序列进行比较以确定变异.
- 遗传差异的生物信息分析.
主要成果:
- 一个新的等位基因被确定,被指定为HLA-DQA1*01:140.
- 这种新型等位基因通过单个核酸替代与HLA-DQA1*01:02:01:01不同.
- 替代位于HLA-DQA1基因的第4个外显子内.
结论:
- 发现HLA-DQA1*01:140扩大了已知的HLA-DQA1等位基因的多样性.
- 这一发现有助于更全面地了解HLA多态性.
- 进一步的研究可能会探索这种新等位基因的潜在功能或临床影响.
相关概念视频
Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...


